Early Start of Biological Treatment in Juvenile Idiopathic Arthritis: Does a Therapeutic Window Exist in Real Life? Alina Boteanu, MD – Hospital Ramón y Cajal
9:00 AM – 11:00 AM ET
Alternative Dosing of Biologic Therapies Is Frequent Among Children with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry Colleen Correll, MD – University of Minnesota
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Longitudinal Effectiveness of Abatacept in JIA: Results from an Ongoing JIA Registry Daniel J. Lovell, MD, MPH – Cincinnati Children's Hospital Medical Center
9:00 AM – 11:00 AM ET
Response to Abatacept in JIA Categories: Results from the PRCSG/PRINTO JIA Abatacept Phase IV Registry Daniel J. Lovell, MD, MPH – Cincinnati Children's Hospital Medical Center
9:00 AM – 11:00 AM ET
JIA-ACR50 Response as a Predictor of Minimal Disease Activity in Patients Aged 2–17 Years with Polyarticular-Course JIA Treated with SC Abatacept Nicolino Ruperto, MD, MPH – IRCCS Istituto Giannina Gaslini; PRINTO, Clinica Pediatrica e Reumatologia
9:00 AM – 11:00 AM ET
Variations in Adalimumab and Etanercept Dosing in Juvenile Idiopathic Arthritis and Their Effect on Treatment Outcome: A Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Study Ruud Verstegen, MD, PhD – The Hospital for Sick Children
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Obesity Impairs Achievement of Clinical Inactive Disease (CID) in Patients with Juvenile Idiopathic Arthritis (JIA) Treated with TNF Inhibitors Fabio Basta, MD – ACURA Rheumatology Center Rhineland-Palatinate
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Long Term Efficacy and Safety of Triamcinolone Hexacetonide versus Triamcinolone Acetonide Intraarticular Injection for Juvenile Idiopathic Arthritis Gil Amarilyo, MD – Schneider Children's Medical Center of Israel
9:00 AM – 11:00 AM ET
Validation of New Antirheumatic Drug Use as a Proxy for Increased JIA Disease Activity Avinash Gabbeta, MD – St. Christopher's Hospital for Children
9:00 AM – 11:00 AM ET
Evaluation of Flare Rate and Tapering Strategies in Juvenile Idiopathic Arthritis Antia Garcia Fernandez, MD – Ramon y Cajal University Hospital
9:00 AM – 11:00 AM ET
Social Determinants of Health and Time to First Pediatric Rheumatology Appointment in Polyarticular Juvenile Idiopathic Arthritis Nayimisha Balmuri, MD – Hospital for Special Surgery
9:00 AM – 11:00 AM ET
Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis (JIA) Correlate with Pain and Stress Using Patient-Reported Outcomes Measurement Information System (PROMIS®) Danielle Fair, MD – Children's Wisconsin
9:00 AM – 11:00 AM ET
A Data Science Evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Questionnaire for Improving Management of JIA Patients Humbert Quesada, PhD – University of California Riverside
9:00 AM – 11:00 AM ET
Who Ordered the Stiff One? Characteristics of Polyarticular Juvenile Idiopathic Arthritis Patients Associated with the Presence and Increased Duration of Joint Stiffness Nayimisha Balmuri, MD – Hospital for Special Surgery
9:00 AM – 11:00 AM ET
Hip Involvement Leads to Poor Outcome in Adulthood in Children with Enthesitis Related Arthritis (ERA) Category of Juvenile Idiopathic Arthritis (JIA) Naveen R, MD – Sanjay Gandhi Post graduate institute of medical sciences
9:00 AM – 11:00 AM ET
Clinical Outcomes of Juvenile Arthritis in Adulthood: A Systematic Review Woo Jin Kim – University of Manitoba (Winnipeg)
9:00 AM – 11:00 AM ET
Morbidity of JIA-associated Uveitis: Half of Patients Despite Systemic Treatment Still Show Ocular Damage During a Long-term Follow-up Francesca Minoia, MD – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
9:00 AM – 11:00 AM ET
To Taper or Not to Taper in Juvenile Idiopathic Arthritis: Is There a Risk of Development of Uveitis Flares? MARIA ANDREINA A. TERAN TINEDO, MD – Hospital Ramón y Cajal
9:00 AM – 11:00 AM ET
Comparing S100 Proteins and Cytokine Levels in Tears Based on Uveitis Activity Laterality in Children with JIA-associated Uveitis and Non-JIA-U Jackeline Rodriguez-Smith, MD – Cincinnati Children's Hospital Medical Center
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Practice Patterns for Tapering Medications in the Treatment of JIA-associated Uveitis Ivan Foeldvari, MD – Hamburger Zentrum für Kinder- und Jugendrheumatologie
9:00 AM – 11:00 AM ET
Differences and Similarities Between down Syndrome-associated Arthritis and Juvenile Idiopathic Arthritis in the New Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Jordan T. Jones, MS, DO – Children's Mercy Kansas City
9:00 AM – 11:00 AM ET
Paediatric Sarcoidosis: Phenotype of a Retrospective Cohort of Biopsy-proven Patients Kerstin A. Nott, MD, PhD – Great Ormond Street Hospital
9:00 AM – 11:00 AM ET
Identification of Salient Resilience Domains Among Adolescents with Chronic Musculoskeletal Pain and Their Parents Sabrina Gmuca, MD, MSc – Children's Hospital of Philadelphia
9:00 AM – 11:00 AM ET
“It’ll Go Away. There’s Nothing Wrong with you:” the Experience of Pain-Related Stigma Among Adolescents with Pain Amplification Syndrome Emily Wakefield, PhD – Connecticut Children's